Rob Stein

Yeah, yeah. I've been following the developments of a biotech company called Revivacor that's been moving towards a very ambitious goal, and that is to use cloned, genetically modified farm animals to provide organs for transplants for humans.

Yeah, yeah. I've been following the developments of a biotech company called Revivacor that's been moving towards a very ambitious goal, and that is to use cloned, genetically modified farm animals to provide organs for transplants for humans.

Yeah, yeah. I've been following the developments of a biotech company called Revivacor that's been moving towards a very ambitious goal, and that is to use cloned, genetically modified farm animals to provide organs for transplants for humans.

Yeah, yeah. In fact, I went to visit this farm. I drove down a road through the Blue Ridge Mountains in southwest Virginia to visit the Rivercore Farm back in February. This farm, it has like 22 buildings and around 300 pigs. We had to change into hospital scrubs before going inside to protect the pigs.

Yeah, yeah. In fact, I went to visit this farm. I drove down a road through the Blue Ridge Mountains in southwest Virginia to visit the Rivercore Farm back in February. This farm, it has like 22 buildings and around 300 pigs. We had to change into hospital scrubs before going inside to protect the pigs.

Yeah, yeah. In fact, I went to visit this farm. I drove down a road through the Blue Ridge Mountains in southwest Virginia to visit the Rivercore Farm back in February. This farm, it has like 22 buildings and around 300 pigs. We had to change into hospital scrubs before going inside to protect the pigs.

They're really careful to make sure visitors don't bring in any pathogens that could infect the pigs. When we went into the buildings, we stepped into these tubs of disinfecting fluid to sterilize our boots. And then I got to see these cloned, genetically modified adult female pigs.

They're really careful to make sure visitors don't bring in any pathogens that could infect the pigs. When we went into the buildings, we stepped into these tubs of disinfecting fluid to sterilize our boots. And then I got to see these cloned, genetically modified adult female pigs.

They're really careful to make sure visitors don't bring in any pathogens that could infect the pigs. When we went into the buildings, we stepped into these tubs of disinfecting fluid to sterilize our boots. And then I got to see these cloned, genetically modified adult female pigs.

And some of them were pregnant with cloned pig embryos that were also genetically modified.

And some of them were pregnant with cloned pig embryos that were also genetically modified.

And some of them were pregnant with cloned pig embryos that were also genetically modified.

That's the idea. That's right. They clone these pigs. They all have these 10 identical genetic modifications, and they're designed to make sure their organs, these piglets that are born, don't grow too big, won't cause complications like blood clots, and won't be rejected by the human immune system.

That's the idea. That's right. They clone these pigs. They all have these 10 identical genetic modifications, and they're designed to make sure their organs, these piglets that are born, don't grow too big, won't cause complications like blood clots, and won't be rejected by the human immune system.

That's the idea. That's right. They clone these pigs. They all have these 10 identical genetic modifications, and they're designed to make sure their organs, these piglets that are born, don't grow too big, won't cause complications like blood clots, and won't be rejected by the human immune system.

It did to me, too, especially when I first heard about it. But it's real. And they're trying to address a very real problem, which is that more than 100,000 people are on the waiting list for transplants in the U.S. And about 17 die every day without getting one because there just aren't enough human organs available.

It did to me, too, especially when I first heard about it. But it's real. And they're trying to address a very real problem, which is that more than 100,000 people are on the waiting list for transplants in the U.S. And about 17 die every day without getting one because there just aren't enough human organs available.

It did to me, too, especially when I first heard about it. But it's real. And they're trying to address a very real problem, which is that more than 100,000 people are on the waiting list for transplants in the U.S. And about 17 die every day without getting one because there just aren't enough human organs available.

Yeah. And last month, I was there for the very first transplant surgery of one of the Rivivacor kidneys with these 10 genetic modifications into a living patient.

Yeah. And last month, I was there for the very first transplant surgery of one of the Rivivacor kidneys with these 10 genetic modifications into a living patient.